Simply Good Foods Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Simply Good Foods Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Aug 29, 2020 | $222.29M | Jun 30, 2021 |
| FY2020 | May 30, 2020 | $215.10M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $227.10M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $152.15M | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | $139.18M | Jun 30, 2021 |
| FY2020 | May 25, 2019 | $139.47M | Jun 30, 2021 |
| FY2020 | Feb 23, 2019 | $123.80M | Jun 30, 2021 |
| FY2020 | Nov 24, 2018 | $121.31M | Jun 30, 2021 |
| FY2019 | Aug 25, 2018 | $108.26M | Oct 30, 2019 |
| FY2019 | May 26, 2018 | $107.23M | Oct 30, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $1.45B | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $1.33B | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $1.24B | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $1.17B | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $1.01B | Oct 24, 2023 |
| FY2022 | Aug 29, 2020 | $816.64M | Oct 21, 2022 |
| FY2020 | Aug 31, 2019 | $139.18M | Jun 30, 2021 |
| FY2020 | May 25, 2019 | $139.47M | Jun 30, 2021 |
| FY2020 | Feb 23, 2019 | $123.80M | Jun 30, 2021 |
| FY2020 | Nov 24, 2018 | $121.31M | Jun 30, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 26, 2017 | $56.33M | Nov 9, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $525.75M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $511.57M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $453.42M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $445.56M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $409.77M | Oct 24, 2023 |
| FY2020 | Aug 29, 2020 | $88.10M | Jun 30, 2021 |
| FY2020 | May 30, 2020 | $88.63M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $85.39M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $62.21M | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | $59.17M | Jun 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $103.61M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $139.31M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $133.58M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $108.57M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $40.88M | Oct 24, 2023 |
| FY2020 | Aug 29, 2020 | ($39.29M) | Jun 30, 2021 |
| FY2020 | May 30, 2020 | $48.11M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $48.30M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $8.52M | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | ($42.23M) | Jun 30, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $156.89M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $206.50M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $204.95M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $202.76M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $173.68M | Oct 24, 2023 |
| FY2020 | Aug 29, 2020 | $24.83M | Jun 30, 2021 |
| FY2020 | May 30, 2020 | $31.11M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $25.27M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | ($2.99M) | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | $12.12M | Jun 30, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $5.50M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $5.40M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $4.30M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $4.10M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $3.50M | Oct 24, 2023 |
| FY2022 | Aug 29, 2020 | $4.00M | Oct 21, 2022 |
| FY2021 | Aug 31, 2019 | $2.20M | Oct 26, 2021 |
| FY2020 | Aug 25, 2018 | $2.50M | Jun 30, 2021 |
| FY2019 | Aug 26, 2017 | $400.0K | Oct 30, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $178.46M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $215.70M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $171.12M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $110.64M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $132.09M | Oct 24, 2023 |
| FY2022 | Aug 29, 2020 | $58.92M | Oct 21, 2022 |
| FY2021 | Aug 31, 2019 | $73.04M | Oct 26, 2021 |
| FY2020 | Aug 25, 2018 | $61.04M | Jun 30, 2021 |
| FY2019 | Aug 26, 2017 | ($27.36M) | Oct 30, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $20.54M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $5.74M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $11.59M | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | $5.23M | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | $5.91M | Oct 24, 2023 |
| FY2022 | Aug 29, 2020 | $1.74M | Oct 21, 2022 |
| FY2021 | Aug 31, 2019 | $1.04M | Oct 26, 2021 |
| FY2020 | Aug 25, 2018 | $1.77M | Jun 30, 2021 |
| FY2019 | Aug 26, 2017 | $458.0K | Oct 30, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $2.40B | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $2.44B | Oct 28, 2025 |
| FY2024 | Aug 26, 2023 | $2.10B | Oct 29, 2024 |
| FY2023 | Aug 27, 2022 | $2.09B | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | $2.05B | Oct 21, 2022 |
| FY2021 | Aug 29, 2020 | $2.01B | Oct 26, 2021 |
| FY2020 | Aug 31, 2019 | $1.14B | Jun 30, 2021 |
| FY2019 | Aug 25, 2018 | $974.61M | Oct 30, 2019 |
| FY2018 | Aug 26, 2017 | $922.49M | Oct 24, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $589.21M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $708.66M | Oct 28, 2025 |
| FY2024 | Aug 26, 2023 | $525.99M | Oct 29, 2024 |
| FY2023 | Aug 27, 2022 | $655.59M | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | $863.41M | Oct 21, 2022 |
| FY2021 | Aug 29, 2020 | $869.11M | Oct 26, 2021 |
| FY2020 | May 30, 2020 | $866.42M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $877.94M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $943.65M | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | $428.78M | Jun 30, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $1.81B | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $1.73B | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $1.57B | Oct 28, 2025 |
| FY2025 | Aug 27, 2022 | $1.44B | Oct 28, 2025 |
| FY2024 | Aug 28, 2021 | $1.19B | Oct 29, 2024 |
| FY2023 | Aug 29, 2020 | $1.14B | Oct 24, 2023 |
| FY2020 | May 30, 2020 | $1.17B | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $1.12B | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $1.07B | Jun 30, 2021 |
| FY2022 | Aug 31, 2019 | $712.87M | Oct 21, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $589.97M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $591.69M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $543.13M | Oct 28, 2025 |
| FY2023 | Aug 27, 2022 | $543.13M | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | $543.13M | Oct 21, 2022 |
| FY2022 | Aug 29, 2020 | $544.77M | Oct 21, 2022 |
| FY2021 | Aug 31, 2019 | $471.43M | Oct 26, 2021 |
| FY2019 | Aug 25, 2018 | $471.43M | Oct 30, 2019 |
| FY2019 | Aug 26, 2017 | $465.03M | Oct 30, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $590.88M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $487.27M | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | $347.96M | Oct 28, 2025 |
| FY2025 | Aug 27, 2022 | $214.38M | Oct 28, 2025 |
| FY2024 | Aug 28, 2021 | $105.81M | Oct 29, 2024 |
| FY2023 | Aug 29, 2020 | $64.93M | Oct 24, 2023 |
| FY2020 | May 30, 2020 | $104.22M | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | $56.11M | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | $7.80M | Jun 30, 2021 |
| FY2022 | Aug 31, 2019 | ($711.0K) | Oct 21, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | $98.47M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | $132.53M | Oct 28, 2025 |
| FY2024 | Aug 26, 2023 | $87.72M | Oct 29, 2024 |
| FY2023 | Aug 27, 2022 | $67.49M | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | $75.35M | Oct 21, 2022 |
| FY2021 | Aug 29, 2020 | $95.85M | Oct 26, 2021 |
| FY2021 | Aug 31, 2019 | $266.34M | Oct 26, 2021 |
| FY2021 | Aug 25, 2018 | $111.97M | Oct 26, 2021 |
| FY2020 | Aug 26, 2017 | $56.50M | Jun 30, 2021 |
| FY2019 | Jul 6, 2017 | $203.0K | Oct 30, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2024 | $397.49M | Oct 29, 2024 |
| FY2024 | Aug 26, 2023 | $281.79M | Oct 29, 2024 |
| FY2023 | Aug 27, 2022 | $403.29M | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | $451.55M | Oct 21, 2022 |
| FY2021 | Aug 29, 2020 | $597.15M | Oct 26, 2021 |
| FY2020 | Aug 31, 2019 | $190.94M | Jun 30, 2021 |
| FY2019 | Aug 25, 2018 | $191.58M | Oct 30, 2019 |
| FY2018 | Aug 26, 2017 | $192.09M | Oct 24, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | 1 | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | 1 | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | 1 | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | 1 | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | 0 | Oct 24, 2023 |
| FY2020 | Aug 29, 2020 | 0 | Jun 30, 2021 |
| FY2020 | May 30, 2020 | 0 | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | 0 | Jun 30, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | 1 | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | 1 | Oct 28, 2025 |
| FY2025 | Aug 26, 2023 | 1 | Oct 28, 2025 |
| FY2024 | Aug 27, 2022 | 1 | Oct 29, 2024 |
| FY2023 | Aug 28, 2021 | 0 | Oct 24, 2023 |
| FY2020 | Aug 29, 2020 | 0 | Jun 30, 2021 |
| FY2020 | May 30, 2020 | 0 | Jun 30, 2021 |
| FY2020 | Feb 29, 2020 | 0 | Jun 30, 2021 |
| FY2020 | Nov 30, 2019 | 0 | Jun 30, 2021 |
| FY2020 | Aug 31, 2019 | 0 | Jun 30, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 30, 2025 | 99.73M | Oct 28, 2025 |
| FY2025 | Aug 31, 2024 | 100.15M | Oct 28, 2025 |
| FY2024 | Aug 26, 2023 | 99.56M | Oct 29, 2024 |
| FY2023 | Aug 27, 2022 | 99.50M | Oct 24, 2023 |
| FY2022 | Aug 28, 2021 | 95.78M | Oct 21, 2022 |
| FY2021 | Aug 29, 2020 | 95.65M | Oct 26, 2021 |
| FY2020 | Aug 31, 2019 | 81.88M | Jun 30, 2021 |
| FY2019 | Aug 25, 2018 | 70.56M | Oct 30, 2019 |
| FY2018 | Aug 26, 2017 | 70.56M | Oct 24, 2018 |